Apheresis: After a patient is evaluated and determined to be a candidate for the therapy, treatment begins with a collection of the patient’s white blood cells, or T cells.
Reprogrammed & Multiplied: Once collected, the T cells are sent to a laboratory where they are modified with the chimeric antigen receptor protein that allows them to recognize the cancer tumor cells. The modified cells then go through a manufacturing process that can take a few weeks.
Infusion: After millions of the CAR-T cells are manufactured, they are frozen and sent to Baylor University Medical Center where they are infused back into the patient’s blood stream.
Cell Death: CAR-T cells then track down and kill the cancer tumor cells in the patient’s body.